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A Study on Mastectomy Samples to Evaluate Breast
Imaging Quality and Potential Clinical Relevance of
Differential Phase Contrast Mammography
Nik Hauser, PhD,* Zhentian Wang, PhD,Þ Rahel A. Kubik-Huch, MD, MPH,þ
Mafalda Trippel, MD,§ Gad Singer, MD,§ Michael K. Hohl, MD,*
Ewald Roessl, PhD,|| Thomas Ko¨hler, PhD,|| Udo van Stevendaal, PhD,||
Nataly Wieberneit, PhD,¶ and Marco Stampanoni, PhDÞ#
Objectives: Differential phase contrast and scattering-based x-ray mammogra-
phy has the potential to provide additional and complementary clinically rele-
vant information compared with absorption-based mammography. The purpose
of our study was to provide a first statistical evaluation of the imaging capa-
bilities of the new technique compared with digital absorption mammography.
Materials and Methods: We investigated non-fixed mastectomy samples of
33 patients with invasive breast cancer, using grating-based differential phase
contrast mammography (mammoDPC) with a conventional, low-brilliance x-ray
tube.We simultaneously recorded absorption, differential phase contrast, and small-
angle scattering signals that were combined into novel high-frequency-enhanced
images with a dedicated image fusion algorithm. Six international, expert breast
radiologists evaluated clinical digital and experimental mammograms in a 2-part
blinded, prospective independent reader study. The results were statistically ana-
lyzed in terms of image quality and clinical relevance.
Results: The results of the comparison of mammoDPC with clinical digital
mammography revealed the general quality of the images to be significantly
superior (P G 0.001); sharpness, lesion delineation, as well as the general visi-
bility of calcifications to be significantly more assessable (P G 0.001); and de-
lineation of anatomic components of the specimens (surface structures) to be
significantly sharper (P G 0.001). Spiculations were significantly better identi-
fied, and the overall clinically relevant information provided by mammoDPC
was judged to be superior (P G 0.001).
Conclusions: Our results demonstrate that complementary information pro-
vided by phase and scattering enhanced mammograms obtained with the
mammoDPC approach deliver images of generally superior quality. This
technique has the potential to improve radiological breast diagnostics.
Key Words: differential phase contrast imaging, mammography, breast
imaging, grating interferometry, reader study
(Invest Radiol 2014;49: 131Y137)
Phase contrast and scattering-based (dark-field) x-ray imaginghas been shown to be potentially revolutionizing radiological
approaches to breast imaging because they are intrinsically capable
of detecting subtle differences in the electron density of the tissue
(phase signal) and of measuring the amount of small-angle scattering
induced by microscopic density fluctuations in the specimen (scat-
tering signal).1Y5 Fully digital absorption-based mammography, the
current clinical standard for screening and diagnosis,6,7 is an imper-
fect modality and has some limitations in sensitivity and false-
positive rates, particularly in women with generally dense breast
tissue and fibroglandular tissue as well as heterogeneously dense and
extremely dense breasts.7Y10 Therefore, mammography could expe-
rience significant gains (ie, soft-tissue contrast enhancement) from
x-ray phase contrast imaging as a highly sensitive, possibly cheap, and
fast method, compared with existing approaches, for example, MRI11
or tomosynthesis.12,13 In a preliminary work, we used grating inter-
ferometry to simultaneously record the differential phase and small-
angle scattering signals of native, whole-breast samples, in addition
to the conventional absorption signal.14 We showed that the comple-
mentary information that was obtained may indeed allow improved
diagnostic capabilities. In this work, we tested the hypothesis that phase
contrast and dark-field signals increase the sharpness and delinea-
tion of lesions within breast tissue and may lead to a generally increased
quality of radiological images. For this purpose, we designed an inter-
national, blinded reader study involving experienced breast radiolo-
gists evaluating several diagnostic aspects on mastectomy images
obtained with both absorption-based clinical digital mammography
and our novel phase contrast-enhanced technique.
Published results so far reported the use of synchrotron ra-
diation15Y18 or fixed, denatured tissue samples.19Y21 Our work pre-
sents phase contrast images of freshly dissected mastectomy samples
obtained with a conventional, low-brilliance x-ray tube evaluated on
the basis of 2 blinded, prospective independent reader studies. We
present a first comprehensive statistical evaluation of the imaging ca-
pabilities of this emerging x-ray technique compared with digital ab-
sorption mammography.
MATERIALS AND METHODS
Study Design
Two prospective reader studies were designed, involving mas-
tectomy specimens of 33 patients and 6 international breast radiologists
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working in certified European breast units and screening programs.
Mammograms of the freshly resected breasts were obtained with
absorption-based clinical digital mammography (Mx-clin). Further-
more, absorption-based digital mammography (Mx-exp) and phase
contrast-enhanced mammography (mammoDPC) were acquired si-
multaneously on an experimental setup as described in the study of
Stampanoni et al.14
The first study (study 1) directly compared images obtained with
our experimental setup in absorption (Mx-exp) and mammoDPC using
the same dose (reported to be 26.2mSv in the study of Stampanoni et al14).
This allows the a priori removal of instrument-specific characteristics and
yields system-unbiased images.Craniocaudal (CC) and anteroposterior (AP)
views were evaluated. Mediolateral (ML) and mediolateral oblique (MLO)
viewswere not considered because they are almost impossible to obtain
with the resected breast. Dedicated questionnaires on the general quality
of the image, sharpness and delineation of the lesions, microcalcifications,
skin involvement, artifacts, and general clinically relevant information
were prepared. Study 1 included 9 comparative questions assessing the
relative strength of phase contrast versus absorption mammograms on a
5-point Likert scale (‘‘highly superior,’’ ‘‘superior,’’ ‘‘equivalent,’’ ‘‘in-
ferior,’’ ‘‘highly inferior’’) with respect to the previously mentioned
criteria. All readers were equally instructed by the same person and
independently evaluated the images presented on screen after the
questionnaire.
The second study (study 2) investigated 3 types of images for
all 33 mastectomy samples: Mx-clin, Mx-exp, and mammoDPC. All
types of mammograms were evaluated independently as randomized
blinded images by the readers. Findings of images obtained with Mx-
clin were compared with those of Mx-exp and mammoDPC. In study
2, only CC views are included because they correspond to the im-
aging plane that is regularly acquired in clinical practice. Also, for
study 2, dedicated questionnaires, including 12 questions evaluating
different aspects as returned by clinical, experimental, and phase
contrast mammography on a multiple-point Likert scale, were pre-
pared. All readers, again, were equally instructed by the same person
and independently evaluated the randomized images presented on
screen after the questionnaire. Because of experimental limitations,
the dose for Mx-exp and mammoDPC was approximately 25 times
larger than the dose for Mx-clin, as explained in the study of
Stampanoni et al.14 This issue does not affect study 1 (comparison of
Mx-exp with mammoDPC with the same dose) and is marginally
relevant for study 2. The higher dose reported for mammoDPC is
mainly caused by the use of an unfiltered source, causing low-energy
photons to be absorbed in the sample and interferometer but, finally,
not contributing to image formation.
Both reader studies were blinded because all readers inde-
pendently evaluated all mammograms taken with the 3 methods in
a randomized order. In reader study 1 in particular, where Mx-exp
was directly compared with mammoDPC, the randomization order
also included 2 view planes (CC and AP).
Histopathological findings were available for all mastectomy
samples included in the study. Identification and localization of
histopathologically proven ductal carcinoma in situ (DCIS) were
used to correlate image readings (positive and negative findings).
All routine hematoxylin-eosin stained slides were reviewed by a
gynecopathologist.
Patients Included and Sample Preparation
The local institution’s ethical review board approved this
study, and written informed consent was obtained from all patients.
Men or women older than 18 years who presented at the depart-
ment of gynecology between November 2010 and April 2012 with
histopathologically confirmed unifocal, multifocal, or multicentric
invasive ductal or lobular breast cancer, with and without addi-
tional DCIS, requiring modified radical mastectomy, and willing
to participate in the study, were considered eligible. Patients who
qualified for breast-conserving operative procedures, skin sparing,
or subcutaneous mastectomy were excluded. The non-fixed tissue
samples were investigated immediately after mastectomy. Breast
density values according to American College of Radiology (ACR)
criteria,22 available from in vivo mammography performed on a
MAMMOMAT Inspiration system (Siemens Healthcare, Erlangen,
Germany) at the department of radiology of the Kantonsspital Baden
1 to 30 days before surgery, were compared with the ex vivo values
provided by the study readers. Table 1 summarizes the histopatho-
logical findings and breast density values of the patients (one 55-year-old
man and 32 women with a mean age of 67 years [range, 43Y93 years])
including the type of invasive carcinoma, histological grade, histo-
pathological presence of additional DCIS, tumor centricity by histo-
pathology, and microscopic skin infiltration.
The surgical procedure involved a modified radical mastec-
tomy followed by a sentinel lymph node dissection and/or a com-
plete axillary lymph node clearance, when clinically indicated. The
removed breast specimen was marked with small metal clips to un-
equivocally identify the 3-dimensional orientation. The breast tissue
samples were then mounted immediately after resection into a dedi-
cated, cooled breast tissue holder, and within 30 to 90 minutes after the
resection, Mx-clin as well as simultaneous Mx-exp and mammoDPC
imaging were performed. The breast tissue holder was designed to
mimic the correct orientation and adequate compression of the tissue
compared with the in vivo situation.14 Absorption mammography of
the breast sample (Mx-clin) was performed with a fully digital system
(MAMMOMAT Inspiration; Siemens Healthcare, Erlangen, Germany).
Formalin fixation and standard histopathological examination were
initiated after the mammoDPC acquisition.
TABLE 1. Histopathological and Radiological Findings of the 33 Cases Included in the Study
Tumor Centricity
Grading,
According to
the TNM
Classification Breast Density (ACR)
No. Cases Unifocal Multifocal Multicentric G1 G2 G3 ACR I ACR II ACR III ACR IV
Invasive ductal carcinoma 28 20 2 6 0 9 19 6 4 9 9
Invasive lobular carcinoma 5 0 0 5 0 5 0 0 0 4 1
Thereof DCIS 22 14 1 7 0 9 13 3 3 6 10
Thereof skin infiltration 11 5 2 4 0 4 7 6 1 2 2
ACR indicates American College of Radiology; DCIS, ductal carcinoma in situ.
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Grating Interferometry and mammoDPC
Measurement
A Talbot-Lau23 grating interferometer with a standard x-ray
tube and a commercial flat panel detector (pixel size, 50  50 Km)
was set up at the Paul Scherrer Institute in Villigen, Switzerland. We
used Seifert ID 3000 x-ray generator, an unfiltered tungsten line
focus tube (operated at 40 kilovolt [peak] with a mean energy of
28 keVand a current of 25 mA), and a 3 grating interferometer (with
periods of p0 = 14 Km, p1 = 3.5 Km, and p2 = 2.0 Km, respectively).
The source-to-detector distance was 1.6 m. Additional details on the
experimental system are given in the study of Stampanoni et al.14
Absorption, phase, and scattering signals were recorded simulta-
neously using a phase-stepping approach, where the absorption grat-
ing is translated perpendicular to the grating direction by a fractional
distance of the grating period, and a Fourier analysis of the resulting
intensity curve returned the previously mentioned signals.24 After
the operation, Mx-clin was performed in the clinic, whereas Mx-exp
and mammoDPC were performed within 30 to 90 minutes after
transport (15-km distance) at the Paul Scherrer Institute in Villigen,
Switzerland. The field of view of the Mx-exp and mammoDPC im-
ages is limited to 5  5 cm2, thus requiring multiple snapshots to be
tiled together to cover the size of the resected breast.
Imaging Protocol and Image Processing
The raw Mx-exp images were processed with the Philips
UNIQUE algorithm,25 which is used in commercial mammography
systems. This ensures that the quality of the processed images cor-
responds to the clinical standard. During the mammoDPC data ac-
quisition, one of the interferometer gratings is moved perpendicular
to the grating lines within at least 1 gratings period (phase-stepping
approach). For each pixel on the detector, a quasi-sine intensity curve
is recorded. The absorption, differential phase, and scattering signals
are obtained by a retrieving algorithm24,26 operating on phase-stepping
curves with and without the object.
The retrieved signals have been effectively fused into a single
and more informative image. The fusion procedure involves merging
the high frequencies of the differential phase signal into the absorp-
tion image by a dedicated algorithm.28 The inclusion of the scattering
image is achieved by fusing it into the merged image by adaptive,
multilevel thresholding.28 It is based on a ‘‘decompose-process and fuse-
reconstruct’’ approach. The absorption, differential phase, and scattering
signals are first decomposed into multiple levels and bands, which rep-
resent image information at different scales and frequencies, with the help
of wavelets decomposition. Furthermore, an intraband processing first
enhances the local signal-to-noise ratio; then, the interband processing
weights each band by considering its characteristics and relative contri-
butions. Finally, the resulting fusion image shows a similar appearance
to that of a conventional mammogram but contains significantly en-
hanced features’details.
Statistical Analysis
The statistical analysis was done by the statistical consulting
service of the Institute of Social and Preventive Medicine, University
of Zurich, Zurich, Switzerland. The Wilcoxon signed rank test was
used for the qualitative analysis of subjective preference score in
both reader studies. IBM Statistical Package for the Social Sciences
Statistics 20 (SPSS Inc, Chicago, IL) was used for the descriptive and
pairwise comparisons (Wilcoxon signed rank test) of image types.
Stata 11.2 (StataCorp, Lakeway Drive, TX) was used for the compu-
tation of J values to evaluate interreader variability. For all statistical
analyses, a 2-tailed P G 0.05 was considered to indicate a statistically
significant difference. For reader study 1, a Bonferroni correction was
made to consider the 9 comparisons per view; therefore, P e 0.05/9
approximately equal to 0.005 was considered significant. For reader
study 2, a total of 2 comparisons per questionwere considered, resulting
in P e 0.05/2 equal to 0.025 for significance. Interobserver agree-
ment between the readers was calculated by weighted J statistics. The
J values in the ranges 0.00 to 0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to
0.80, and 0.81 to 1.00 were considered to represent slight agreement,
fair agreement, moderate agreement, substantial agreement, and almost
perfect agreement, respectively.
RESULTS
Reader Study 1
The results of the statistical analysis revealed the general qua-
lity of the mammoDPC images to be significantly superior than that of
the Mx-exp based images (P G 0.001; median of 2 with an interquartile
range [IQR] of 2-3, with 2 being ‘‘superior’’ and 3 being ‘‘equivalent’’).
Furthermore, the sharpness and lesion delineation as well as the gene-
ral visibility of calcifications were rated as significantly more assess-
able on mammoDPC than on Mx-exp (P G 0.001; median of 2 with
an IQR of 2-3, with 2 being ‘‘superior’’ and 3 being ‘‘equivalent’’).
MammoDPC images resulted in a sharper delineation of anatomic
components of the specimens (surface structures) when evaluating the
periphery of the images (P G 0.001; median of 2 with an IQR of 2-2,
with 2 being ‘‘superior’’), with 75% of the readings indicating that
mammoDPC was better than Mx-exp. Table 2 summarizes the results.
Reader Study 2
Spiculations could be significantly better identified in mammoDPC
images compared with Mx-clin (P G 0.015), whereas Mx-exp images
were shown to be directly comparable with the Mx-clin mammograms
(P G 0.076) (Figs. 1 and 2C, D). Blood vessel visibility was lower in the
mammoDPC and Mx-exp images, when compared with the Mx-clin
mammograms (Table 3).
Microcalcifications
The presence of clusters of suspicious microcalcifications was
similarly observed in mammoDPC with respect to Mx-exp. No sta-
tistically significant difference (P = 0.2) was observed (Table 3). On
the other hand, significantly superior findings of calcification sharp-
ness (Table 2) were seen in mammoDPC compared with Mx-exp
(P G 0.001; median of 2 with an IQR of 2-3, with 2 being ‘‘superior’’
and 3 being ‘‘equivalent’’) (Figs. 1A, B and 2A, B).
TABLE 2. Statistical Outcome Showing the Criteria Under Which
mammoDPC Is Superior to Absorption-Based Mammography
Evaluated Criteria (mammoDPC Is Superior) P* IQR
General quality of image G0.001 2Y3†
Sharpness and lesion delineation G0.001 2Y3
Delineation of surface structures G0.001 2Y3
Sharpness of microcalcifications G0.001 2Y2
General visibility of microcalcifications G0.001 2Y3
Potentially clinically relevant information G0.001 4Y5‡
Identification of spiculations G0.015§
*P G 0.005 is considered to be significant with Bonferroni correction.
†2 being ‘‘superior’’ and 3 being ‘‘equivalent’’ quality.
‡4 being ‘‘11% to 20% superior’’ and 5 being ‘‘1% to 10% superior.’’
§This criterion was evaluated in study 2. P G 0.025 is significant with the
Bonferroni correction.
IQR indicates interquartile range; mammoDPC, phase contrast-enhanced
mammography.
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Ductal Carcinoma In Situ
We analyzed the ability of Mx-clin, Mx-exp, and mammoDPC
imaging to detect microcalcifications interpreted by the readers as
suggestive of DCIS. Although the results were not statistically sig-
nificant (Table 3), we observed that mammoDPC returned more true
findings (64%, positives and negatives) than did Mx-exp (56%) and
Mx-clin (59%) when related to the criterion standard provided by the
histopathological examination. It must be stated, however, that we
obtained a considerable amount of false negatives (36%, 37%, and
29% for Mx-clin, Mx-exp, and mammoDPC, respectively) for this
diagnostic question, with a moderate level of interreader agreement
(J = 0.400). Because of the inclusion criteria of the study, there was
only 1 patient with no radiological signs of invasive carcinoma. This
patient had a very small invasive carcinoma (pT1a), surrounded by an
extended DCIS. All other patients showed histopathological findings
consistent with an invasive carcinoma of pT1b or higher. This was
successfully indicated by all 3 methods, with 91% of true positives
for mammoDPC compared with 87% for both Mx-exp and Mx-clin.
This difference was not statistically significant and the level of
interreader agreement was moderate (J = 0.546).
Artifacts
Minor or no imaging artifacts (like abnormal edge enhancement)
were detected in most of the readings (94%, 97%, 82% for Mx-clin,
Mx-exp, and mammoDPC, respectively). More generally, mammoDPC
generated significantly stronger artifacts than did Mx-clin (P G 0.001),
whereas it was comparable with Mx-exp (P = 0.047 with a threshold of
0.025 for significance, according to Bonferroni). The presence of new
types of artifacts, generated by the intrinsic physics of the novel signals
and the experimental arrangement, led to a slight change in interpre-
tation, but it did not affect the diagnostic content. Among the pic-
tures showing artifacts (disregarding air bubbles and non-tissue related
FIGURE 1. A and B, Craniocaudal view of native breast tissue sample after mastectomy. C and D, Anteroposterior view of the
same breast sample. A and C were obtained with mammoDPC; B and D, with Mx-exp. A sharpness increase in mammoDPC was
observed for microcalcifications (A) and for spiculations (C). Visibility and delineation of structural details were improved in
mammoDPC (A, C) compared with Mx-exp (B, D). The scale bar in A and C is 2 cm.
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structures due to the experimental arrangement), 75% of the read-
ings classified those artifacts in mammoDPC as significantly stronger
than those in Mx-clin (P G 0.001; an IQR of 2-2, with 2 being ‘‘stron-
ger’’ and 3 being ‘‘equivalent’’). In reader study 2, air bubbles or other
non-tissue related structures were identified for all mammography
techniques by all readers. Specifically, with Mx-clin, air bubbles were
visible in 88% of the readings, whereas Mx-exp and mammoDPC
showed these artifacts in 95% and 99% of the readings, respectively.
This difference was not statistically significant.
Skin Infiltration
Approximately one third of the tumors showed histopathologi-
cally confirmed skin infiltration. No significant differences were found
in the abilities of the 3 approaches to detect signs of skin infiltration
(skin retraction and/or skin thickening; Table 3). However, the number
of cases was insufficient for a sound statistical analysis. The level of
interreader agreement for this evaluation was fair (J = 0.236).
Potentially Clinically Relevant Information
One of the most challenging questions was related to the amount
of potentially clinically relevant information provided by the novel method
to the readers according to their individual judgments weighted by their
expertise. The readers compared all pairs of images and indicated an
amount of potentially superior or inferior clinically relevant information
of Mx-exp compared with mammoDPC. Excluding equivalent findings
(72%) resulted in a significant superiority of the mammoDPC tech-
nique with respect to Mx-exp (P G 0.001; median of 5 with an IQR
of 4-5, with 5 being ‘‘1% to 10% superior’’ and 4 being ‘‘11% to 20%
superior’’).
The ACR breast density values evaluated among all 3 imaging
protocols were not significantly different from those of in vivo mam-
mography (considered as the criterion standard), demonstrating that, as
FIGURE 2. Anteroposterior (AYB) and CC (CYD) views of a native breast tissue sample from 2 different patients after mastectomy.
A and C were obtained with mammoDPC; B and D, with Mx-exp. Looking at the margin between lesions and the surrounding
tissue, one can observe a sharper delineation of surface structures in mammoDPC (A) compared with Mx-exp (B), particularly at the
periphery of the images. Furthermore, mammoDPC showed a generally superior visibility and sharpness of the microcalcifications
(C vs D). The scale bar is 2 cm.
TABLE 3. Statistical Outcome Showing the Criteria Under Which
mammoDPC Is Inferior/Equivalent to Absorption-Based
Mammography
Evaluated Criteria (mammoDPC Is Inferior) P*
Lower blood vessel visibility G0.018
More artifacts G0.001
Signs of skin infiltration N/A†
Clusters suggestive of microcalcifications N/A
Signs of the presence of DCIS N/A
*P G 0.025 is considered to be significant with the Bonferroni correction.
†No significance was found.
DCIS indicates ductal carcinoma in situ; mammoDPC, phase contrast-
enhanced mammography.
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expected, Mx-clin as well as Mx-exp and mammoDPC did not af-
fect breast density scoring. The level of interreader agreement for this
evaluation was moderate (J = 0.480).
DISCUSSION
The mammoDPC images were preferred over the Mx-clin and
Mx-exp mammograms with respect to potential clinical relevance,
according to the general quality of the mammoDPC images, sharp-
ness and lesion delineation as well as the general visibility of calci-
fications, sharper delineation of anatomic components of the specimen,
and spiculation visibility. This preference was statistically significant
when the number of equivalent findings was excluded from the analy-
sis. This result can be explained by the fact that the study was carried
out exclusively with mastectomy samples, that is, where a malignant
process was previously identified.
The identification of DCIS in the mammograms proved to be
difficult for all readers. Because no patient with only DCIS was in-
cluded in the study, the diagnostic challenge was to identify DCIS
within or surrounding an invasive carcinoma.
Blood vessel visibility was found to be lower in mammoDPC
and Mx-exp than in Mx-clin (P = 0.017 for mammoDPC vs Mx-clin
with a threshold of 0.025 for significance, according to Bonferroni;
Table 3). This evidence may also be a consequence of the study de-
sign. The Mx-clin mammogram was taken only a few minutes after
the resection, when blood was still in the vessels and could contrib-
ute to the contrast. The Mx-exp and mammoDPC were performed
within 30 to 90 minutes, but during this time, the remaining blood
redistributed within the sample. As the sample is mounted into the
dedicated breast holder with a compression that simulates clinical
standards, a loss of blood occurs and affects the contrast in the sub-
sequent investigation. This interpretation is supported by the finding
that mammoDPC and Mx-exp showed comparable readings with
respect to blood vessel visibility (P = 0.25).
The results of the evaluation of signs for skin infiltration did
not reveal any significant differences between the 3 methods. Therefore,
mammoDPC does not affect, either positively or negatively, the ability to
identify signs of skin infiltration (Table 3).
Existing scar tissue due to previous surgical interventions con-
sists of a different extracellular matrix structure29,30 resulting from
a change in the quantity and type of collagens and noncollagenous
components, when compared with regular breast tissue, and is well
detectable by mammoDPC, as shown in Figure 3. This is caused by the
high sensitivity of the technique to the scattering power of the investi-
gated sample. Similarly, nontissue material present in the breast such
as stitches that usually consist of strongly scattering textile wires cannot
be detected by Mx-clin but is strongly enhanced by mammoDPC.
Study Limitations
Because of the inclusion criteria of our study design, 33 breast
samples of all patients screened during the allocated time frame have
been included. Despite being blinded, the readers quickly learned how
to differentiate between Mx-clin/Mx-exp and mammoDPC because
of the striking sharpness increase of the edges within the mammoDPC
images. This was unavoidable because mammoDPC is expected to in-
crease sharpness in general. The ‘‘tiling’’ artifact due to the limited field
of view observed in both the Mx-exp and mammoDPC images was
not reported to be a disturbing factor in the reading process. Never-
theless, an ongoing study (unpublished) demonstrates that gratings can
be successfully stitched to cover a much larger field of view, eliminat-
ing every tiling artifact in future experiments. Furthermore, the readers
may be biased by the fact that they had to read images of mastectomy
samples because, as a consequence of the study design, no resected
whole-breast sample without invasive carcinoma was included. The
strong enhancement of fine details, due to the boost in high-frequency
content by the differential phase contrast,28 was sometimes ranked as
an artifact. This may have arisen because the radiologists involved in
the study were trained to interpret absorption-based mammograms. We
are aware that radiologists interpreting mammograms must be particu-
larly attuned to the detection of the presence of microcalcifications,
which can also be considered high-frequency image data. However,
FIGURE 3. A and B, Craniocaudal view of native breast tissue after mastectomy. C and D, Anteroposterior view of the same
breast. The patient underwent a breast-conserving intervention before mastectomy. A and C were obtained with mammoDPC;
B and D, with Mx-exp. In the mammoDPC image, signals from scars (arrowheads) and internal stitches (double-headed arrows) are
clearly visible. In the Mx-exp images, the stitches are invisible, whereas the scars are barely seen. The scale bar is 2 cm.
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microcalcifications are normally identified as bright, localized spots,
whereas the previously mentioned frequency boosting happens all over
the image. Also, there was no presence of microcalcifications but only
subtle tissue changes. The mean glandular dose for a 4.5 cm thick
breast sample was measured with a PTW-UNIDOS instrument to be
26.2 mSv for both mammoDPC and Mx-exp, as described in the study
of Stampanoni et al.14 The high delivered dose (25 times higher
as recommended in the European guidelines31) is mainly caused by the
nonoptimized design of the experimental instrument. Because of its
low photon efficiency, the delivered dose is deliberately tuned higher
to be able to generate Mx-exp images with similar image quality to that
of Mx-clin images for fair comparison. With an optimized design
of each component, as described in the study of Stampanoni et al,14
the dose could be reduced by more than 1 order of magnitude while
maintaining the same image quality.
With this study, we have demonstrated, for the first time, that
phase contrast-enhanced mammograms of mastectomy samples obtained
using a conventional x-ray source have significantly higher diagnostic
content compared with that of classically digital absorption-based images
for the evaluated criteria as summarized in Table 2. Differential phase
contrast mammography may have the potential to advance as a new di-
agnostic tool and eventually outperform recently introduced approaches,
for instance, the use of monochromatic x-rays for digital mammogra-
phy.32 So far, no other imaging technology is capable of exploiting x-ray
differential phase and scattering signals to significantly improve soft tis-
sue imaging. These results are promising toward the use of phase contrast
grating interferometry in vivo in a clinical setting. On the basis of our
experience,14 we expect this technology to be further developed and in-
tegrated into an optimized prototype performing at dose depositions
lower or (at worst) comparable with present, approved instruments. The
complementary information provided by phase and scattering-enhanced
mammograms delivers images of generally superior quality. As a con-
sequence, this technique has the potential to improve radiological breast
diagnostics.
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